Showing results (2391-2400 of 13,176) with videos related to
Sort By:
Pageof 1,318
Diabetes Care|September 13, 2014
Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT1 and SGLT2, in patients with type 2 diabetes on metformin monotherapyJulio Rosenstock, William T Cefalu, Pablo Lapuerta, et al.Diabetes Care|October 16, 2014
Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetesPatrick J O'Connor, Julie A Schmittdiel, Ram D Pathak, et al.Diabetes Care|October 16, 2014
Contributory factors to unsteadiness during walking up and down stairs in patients with diabetic peripheral neuropathyJoseph C Handsaker, Steven J Brown, Frank L Bowling, et al.Diabetes Care|September 7, 2014
Longitudinal development of left ventricular diastolic function in patients with type 2 diabetesLaura Venskutonyte, Christina Jarnert, Lars Rydén, et al.Diabetes Care|September 7, 2014
New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2)Hannele Yki-Järvinen, Richard Bergenstal, Monika Ziemen, et al.Diabetes Care|June 20, 2013
Effects of a combined aerobic and resistance exercise program on C1q/TNF-related protein-3 (CTRP-3) and CTRP-5 levelsHae Yoon Choi, Ji Woo Park, Namseok Lee, et al.Diabetes Care|May 25, 2013
Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experienceDiabetes Care|May 1, 2013
Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levelsQichen Fang, Huating Li, Qianqian Song, et al.Diabetes Care|May 1, 2013
Receiver operating characteristic analysis of HLA, CTLA4, and insulin genotypes for type 1 diabetesAna M Valdes, Michael D Varney, Henry A Erlich, et al.Pageof 1,318